Literature DB >> 207646

Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt's lymphoma.

G Klein, E Yefenof, K Falk, A Westman.   

Abstract

Virus production, EBV (P3HR-1 substrain) superinfectability, IdUrd inducibility, EBV receptor and complement (C3) receptor expression were assessed in two independently maintained jijoye lines, the derived P3HR-1 clone that releases a growth inhibitory and cytopathic, non-transforming viral mutant, and in non-producer sublines derived from the P3HR-1 line by the spontaneous cessation of virus production. Both jijoye lines were superinfectable, inducible, and carried EBV and C3 receptors. Virus-producing P3HR-1 cells and recently derived non-producer sublines lacked EBV-receptors and C3 receptors, could not be superinfected, but were IdUrd inducible. Two long-passaged, non-producer sublines of P3HR-1 reexpressed EBV and C3 receptors to an equal degree (different in the two sublines). EBV-superinfectability became partially reestablished in the subline with the higher expression of EBV and C3 receptors. These findings support the hypothesis that the EBV-receptor/C3 receptor negativity of the producer P3HR-1 sublines and their recent non-producer derivatives is due to negative selection by the growth-inhibitory, cytopathic P3HR-1 virus variant. The closely linked disappearance and reappearance of EBV-receptors and complement receptors gives further support to the idea that these two receptors are either identical or closely linked constituents of the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207646     DOI: 10.1002/ijc.2910210504

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).

Authors:  G R Nemerow; R Wolfert; M E McNaughton; N R Cooper
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

2.  Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells.

Authors:  A Wells; N Koide; G Klein
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

3.  gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.

Authors:  R Frade; M Barel; B Ehlin-Henriksson; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

4.  Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression.

Authors:  D J Volsky; I M Shapiro; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines.

Authors:  C Bogedain; P Alliger; F Schwarzmann; M Marschall; H Wolf; W Jilg
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

6.  A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes.

Authors:  S Paulie; B Ehlin-Henriksson; H Mellstedt; H Koho; H Ben-Aissa; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

7.  Differential expression of the major histocompatibility antigen complex (MHC) on a series of Burkitt's lymphoma lines.

Authors:  T Yokochi; Y Inoue; H Iwata; T Miyadai; Y Kimura
Journal:  Microbiol Immunol       Date:  1987       Impact factor: 1.955

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.